Protalix (PLX) Affirms Talks, Engages Citigroup as Advisor

Protalix BioTherapeutics, Inc. (AMEX: PLX) confirms, in response to inquiries received this morning and a report appearing in the Israeli press, that the company has engaged Citigroup to assist it in reviewing a broad array of product partnering, technology sharing and other strategic alternatives. There is no assurance that Protalix will undertake any such strategic alternative.

Protalix will not comment further on this initiative unless future events would make doing so appropriate.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Hibbett (HIBB) soars 18% on deal to sell to JD Sports for $1.08 billion
• Citi updates its outlook for Lucid stock. Here's where it expects LCID shares to trade
• Yum! Brands (YUM) PT Lowered to $162 at Citi